[Research Report] The drug delivery market size is expected to grow from US$ 20,99,856.7 million in 2022 to US$ 32,54,594.2 million by 2028; it is estimated to record a CAGR of 7.7% from 2023 to 2028.
The drug delivery market is segmented based on route of administration, distribution channel, end user, and geography. The report offers insights and in-depth market analysis, emphasizing parameters such as drivers, trends, opportunities, and competitive landscape analysis of leading market players across various regions. It also includes analyses of the impact of the COVID-19 pandemic across major regions.
Market Insights
Growing Demand for Noninvasive Drug Delivery Systems Drives Drug Delivery Market
Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.
A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.
Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Drug Delivery Market: Strategic Insights
Market Size Value in US$ 20,99,856.7 million in 2022 Market Size Value by US$ 32,54,594.2 million by 2028 Growth rate CAGR of 7.7% from 2023 to 2028 Forecast Period 2023-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Drug Delivery Market: Strategic Insights
| Market Size Value in | US$ 20,99,856.7 million in 2022 |
| Market Size Value by | US$ 32,54,594.2 million by 2028 |
| Growth rate | CAGR of 7.7% from 2023 to 2028 |
| Forecast Period | 2023-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Route of Administration-Based Insights
Based on the route of administration, the drug delivery market is segmented into oral drug delivery, injectable drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. In 2022, the injectable drug delivery segment held the largest share of the drug delivery market. However, the topical drug delivery segment is anticipated to register the highest CAGR during the forecast period. Injectable drug delivery is considered one of the effective routes of drug administration due to the speed and effectiveness of delivery to the target site and improved patient experience. The injections help administer drugs, vaccines, or any other therapeutic agents into the body. The drug delivery technique via a route other than the digestive tract is termed parenteral. The parenteral route of administration includes intramuscular, subcutaneous, and intravenous. The development of needle-free injectors has improved insulin drug delivery by reducing the risk of needlestick injuries in diabetic patients.
Increasing usage of injections in complex drug delivery procedures due to advancements in injectable drug delivery systems and the introduction of next-generation injectable devices with superior functional capabilities enhance the global drug delivery market growth for the injectable drug delivery segment.
Distribution Channel-Based Insights
Based on distribution channel, the drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2022 and is expected to record the highest CAGR during the forecast period.
Drug Delivery Market, by Route of Administration– 2022–2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User-Based Insights
Based on end user, the drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment accounted for the largest market share in 2022 and is projected to record the highest CAGR during the forecast period.
The drug delivery market players adopt organic strategies such as product launch and expansion to expand their geographic footprint and product portfolios and meet the growing demands. Inorganic growth strategies adopted by market players allow them to expand their businesses and enhance their geographic presence. Additionally, these growth strategies help companies strengthen their clientele and enlarge their product portfolios.
- In September 2022, Becton, Dickinson, and Company introduced a next-generation glass pre-fillable syringe (PFS) and set a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination, and integrity. The new BD Effivax glass pre-fillable syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.
- In June 2022, Pfizer Inc. strengthen its commitment to United States manufacturing with a US$120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir tablets and ritonavir tablets). The investment expanded the production of active pharmaceutical ingredients (API) and registered starting materials (RSMs) used to manufacture nirmatrelvir.
Company Profiles
- Becton Dickinson and Co
- Novo Nordisk AS
- Johnson & Johnson
- Boston Scientific Corp
- Pfizer Inc.
- Baxter International Inc
- Gerresheimer AG
- Kindeva Drug Delivery LP
- GlaxoSmithKline Plc
- Bausch Health Companies
- Novartis AG
- Sever Pharma Solutions
- Boehringer Ingelheim International
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Route of Administration, Distribution Channel, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The drug delivery market is analyzed in the basis of route of administration, distribution channel, and end user. Based on route of administration, is segmented into oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest market share in 2022. However, topical drug delivery segment is anticipated to register the highest CAGR during the forecast period.
The drug delivery market majorly consists of the players such as Pfizer Inc, Johnson & Johnson, Becton Dickinson and Co, Novo Nordisk AS, Boston Scientific Corp, Baxter International Inc, Gerresheimer AG, Kindeva Drug Delivery LP, GlaxoSmithKline Plc, Bausch Health Companies, Novartis AG, Sever Pharma Solutions, Boehringer Ingelheim International.
Drug delivery are various methodologies used to inject drugs or chemicals into the body. Some of the drug delivery available in the market include, transmucosal, oral, injectable, topical, implantable, and ocular among others. Drug delivery are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.
The factors that are driving the growth of market are growth are rising incidence of chronic diseases, growing demand for noninvasive drug delivery systems, and increasing R&D expenditures in pharmaceutical companies propel the market growth.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Drug Delivery Market – by Route of Administration
1.3.2 Global Drug Delivery Market – by Distribution Channel
1.3.3 Global Drug Delivery Market – by End User
1.3.4 Global Drug Delivery Market – by Geography
2. Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Drug Delivery Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. Drug Delivery Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis
6. Drug Delivery Market – Global Analysis
6.1 Global Drug Delivery Market Revenue Forecast and Analysis
6.2 Global Drug Delivery Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Drug Delivery Market – Revenue and Forecast to 2028 – By Route of Administration
7.1 Overview
7.2 Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
7.3.1 Overview
7.3.2 Injectable Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Conventional Injection Devices
7.3.2.1.1 Overview
7.3.2.1.2 Conventional Injection Devices: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Advanced Devices
7.3.2.2.1 Overview
7.3.2.2.2 Advanced Devices: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
7.4.1 Overview
7.4.2 Oral Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Solid Oral Drugs
7.4.2.1.1 Overview
7.4.2.1.2 Solid Oral Drugs: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Liquid Oral Drugs
7.4.2.2.1 Overview
7.4.2.2.2 Liquid Oral Drugs: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Semi-solid Oral Drugs
7.4.2.3.1 Overview
7.4.2.3.2 Semi-solid Oral Drugs: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Semi-solid Topical Drug Delivery
7.5.2.1.1 Overview
7.5.2.1.2 Semi-solid Topical Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Liquid Topical Drug Delivery Formulations
7.5.2.2.1 Overview
7.5.2.2.2 Liquid Topical Drug Delivery Formulations: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Solid Topical Drug Delivery Formulations
7.5.2.3.1 Overview
7.5.2.3.2 Solid Topical Drug Delivery Formulations: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Transdermal
7.5.2.4.1 Overview
7.5.2.4.2 Transdermal Patches: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
7.6.1 Overview
7.6.2 Transmucosal Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 Pulmonary and Nasal Drug Delivery
7.6.2.1.1 Overview
7.6.2.1.2 Pulmonary and Nasal Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.2 Buccal and Sublingual Drug Delivery
7.6.2.2.1 Overview
7.6.2.2.2 Buccal and Sublingual Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.3 Rectal Transmucosal Drug Delivery
7.6.2.3.1 Overview
7.6.2.3.2 Rectal Transmucosal Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.4 Vaginal Transmucosal Drug Delivery
7.6.2.4.1 Overview
7.6.2.4.2 Vaginal Transmucosal Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
7.7.1 Overview
7.7.2 Implantable Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
7.8.1 Overview
7.8.2 Ocular Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 Eye Drops and Sprays
7.8.2.1.1 Overview
7.8.2.1.2 Eye Drops and Sprays: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.2 Gels and Ointments
7.8.2.2.1 Overview
7.8.2.2.2 Gels and Ointments: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.3 Ocular Inserts and Punctal Plugs
7.8.2.3.1 Overview
7.8.2.3.2 Ocular Inserts and Punctal Plugs: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.4 Therapeutic Contact Lens
7.8.2.4.1 Overview
7.8.2.4.2 Therapeutic Contact Lens: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Drug Delivery Market – Revenue and Forecast to 2028 – By Distribution Channel
8.1 Overview
8.2 Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies0
8.5.1 Overview0
8.5.2 Online Pharmacies: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)0
9. Global Drug Delivery Market – Revenue and Forecast to 2028 – By End User1
9.1 Overview1
9.2 Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)1
9.3 Hospitals and Clinics2
9.3.1 Overview2
9.3.2 Hospitals and Clinics: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)2
9.4 Home Care Settings3
9.4.1 Overview3
9.4.2 Home Care Settings: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)3
9.5 Other End User4
9.5.1 Overview4
9.5.2 Other End User: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)4
10. Drug Delivery Market – Revenue and Forecast to 2028 – Geographic Analysis5
10.1 North America: Drug Delivery Market5
10.1.1 Overview5
10.1.2 North America: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)6
10.1.3 North America: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)6
10.1.3.1 North America: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)7
10.1.3.2 North America: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)7
10.1.3.3 North America: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)7
10.1.3.4 North America: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)8
10.1.3.5 North America: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)8
10.1.4 North America: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)8
10.1.5 North America: Drug Delivery Market, by End User 2020-2028 (US$ Million)9
10.1.6 North America: Drug Delivery Market, by Country, 2022 & 2028 (%)9
10.1.6.1 US: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.1.6.1.1 Overview0
10.1.6.1.2 US: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)1
10.1.6.1.3 US: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)1
10.1.6.1.3.1 US: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)2
10.1.6.1.3.2 US: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)2
10.1.6.1.3.3 US: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)2
10.1.6.1.3.4 US: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)3
10.1.6.1.3.5 US: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)3
10.1.6.1.4 US: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)4
10.1.6.1.5 US: Drug Delivery Market, by End User 2020-2028 (US$ Million)4
10.1.6.2 Canada: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
10.1.6.2.1 Overview5
10.1.6.2.2 Canada: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)6
10.1.6.2.3 Canada: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)6
10.1.6.2.3.1 Canada: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)7
10.1.6.2.3.2 Canada: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)7
10.1.6.2.3.3 Canada: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)7
10.1.6.2.3.4 Canada: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)8
10.1.6.2.3.5 Canada: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)8
10.1.6.2.4 Canada: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)9
10.1.6.2.5 Canada: Drug Delivery Market, by End User 2020-2028 (US$ Million)9
10.1.6.3 Mexico: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.1.6.3.1 Overview0
10.1.6.3.2 Mexico: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.1.6.3.3 Mexico: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)1
10.1.6.3.3.1 Mexico: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)2
10.1.6.3.3.2 Mexico: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)2
10.1.6.3.3.3 Mexico: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)2
10.1.6.3.3.4 Mexico: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)3
10.1.6.3.3.5 Mexico: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)3
10.1.6.3.4 Mexico: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)4
10.1.6.3.5 Mexico: Drug Delivery Market, by End User 2020-2028 (US$ Million)4
10.2 Europe: Drug Delivery Market5
10.2.1 Overview5
10.2.2 Overview5
10.2.3 Europe: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
10.2.4 Europe: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)6
10.2.4.1 Europe: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)6
10.2.4.2 Europe: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)7
10.2.4.3 Europe: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)7
10.2.4.4 Europe: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)7
10.2.4.5 Europe: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)8
10.2.5 Europe: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)8
10.2.6 Europe: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.2.7 Europe: Drug Delivery Market, by Country, 2022 & 2028 (%)9
10.2.7.1 UK: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.2.7.1.1 Overview9
10.2.7.1.2 UK: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.2.7.1.3 UK: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.2.7.1.3.1 UK: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.1.3.2 UK: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.1.3.3 UK: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.1.3.4 UK: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)2
10.2.7.1.3.5 UK: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.2.7.1.4 UK: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)2
10.2.7.1.5 UK: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.2.7.2 Germany: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.2.7.2.1 Overview4
10.2.7.2.2 Germany: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.2.7.2.3 Germany: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.2.7.2.3.1 Germany: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)5
10.2.7.2.3.2 Germany: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.2.3.3 Germany: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.2.3.4 Germany: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.2.3.5 Germany: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.2.7.2.4 Germany: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)7
10.2.7.2.5 Germany: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.2.7.3 France: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.2.7.3.1 Overview9
10.2.7.3.2 France: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.2.7.3.3 France: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.2.7.3.3.1 France: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)0
10.2.7.3.3.2 France: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.3.3.3 France: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.3.3.4 France: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.3.3.5 France: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.2.7.3.4 France: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)2
10.2.7.3.5 France: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.2.7.4 Spain: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.2.7.4.1 Overview4
10.2.7.4.2 Spain: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.2.7.4.3 Spain: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.2.7.4.3.1 Spain: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)5
10.2.7.4.3.2 Spain: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.4.3.3 Spain: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.4.3.4 Spain: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.4.3.5 Spain: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.2.7.4.4 Spain: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)7
10.2.7.4.5 Spain: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.2.7.5 Italy: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.2.7.5.1 Overview9
10.2.7.5.2 Italy: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.2.7.5.3 Italy: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.2.7.5.3.1 Italy: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)0
10.2.7.5.3.2 Italy: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.5.3.3 Italy: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.5.3.4 Italy: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)1
10.2.7.5.3.5 Italy: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.2.7.5.4 Italy: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)2
10.2.7.5.5 Italy: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.2.7.6 Rest of Europe: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.2.7.6.1 Overview4
10.2.7.6.2 Rest of Europe: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.2.7.6.3 Rest of Europe: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.2.7.6.3.1 Rest of Europe: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)5
10.2.7.6.3.2 Rest of Europe: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.6.3.3 Rest of Europe: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.6.3.4 Rest of Europe: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)6
10.2.7.6.3.5 Rest of Europe: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.2.7.6.4 Rest of Europe: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)7
10.2.7.6.5 Rest of Europe: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.3 Asia Pacific: Drug Delivery Market9
10.3.1 Overview9
10.3.2 Asia Pacific: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.3.3 Asia Pacific: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.3.3.1 Asia Pacific: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)1
10.3.3.2 Asia Pacific: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.3.3.3 Asia Pacific: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.3.3.4 Asia Pacific: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)2
10.3.3.5 Asia Pacific: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.3.4 Asia Pacific: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)2
10.3.5 Asia Pacific: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.3.6 Asia Pacific: Drug Delivery Market, by Country, 2022 & 2028 (%)3
10.3.6.1 China: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.1.1 Overview4
10.3.6.1.2 China: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.1.3 China: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.3.6.1.3.1 China: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)5
10.3.6.1.3.2 China: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.1.3.3 China: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.1.3.4 China: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.1.3.5 China: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.3.6.1.4 China: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)7
10.3.6.1.5 China: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.3.6.2 Japan: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.3.6.2.1 Overview9
10.3.6.2.2 Japan: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.3.6.2.3 Japan: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.3.6.2.3.1 Japan: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)0
10.3.6.2.3.2 Japan: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.2.3.3 Japan: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.2.3.4 Japan: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.2.3.5 Japan: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.3.6.2.4 Japan: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)2
10.3.6.2.5 Japan: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.3.6.3 India: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.3.1 Overview4
10.3.6.3.2 India: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
10.3.6.3.3 India: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.3.6.3.3.1 India: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.3.3.2 India: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.3.3.3 India: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.3.3.4 India: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)7
10.3.6.3.3.5 India: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.3.6.3.4 India: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)7
10.3.6.3.5 India: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.3.6.4 South Korea: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.3.6.4.1 Overview9
10.3.6.4.2 South Korea: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.3.6.4.3 South Korea: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.3.6.4.3.1 South Korea: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.4.3.2 South Korea: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.4.3.3 South Korea: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.4.3.4 South Korea: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)2
10.3.6.4.3.5 South Korea: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.3.6.4.4 South Korea: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)3
10.3.6.4.5 South Korea: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.3.6.5 Australia: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.5.1 Overview4
10.3.6.5.2 Australia: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
10.3.6.5.3 Australia: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.3.6.5.3.1 Australia: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.5.3.2 Australia: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.5.3.3 Australia: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.3.6.5.3.4 Australia: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)7
10.3.6.5.3.5 Australia: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.3.6.5.4 Australia: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)8
10.3.6.5.5 Australia: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.3.6.6 Rest of Asia Pacific: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.3.6.6.1 Overview9
10.3.6.6.2 Rest of Asia Pacific: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.3.6.6.3 Rest of Asia Pacific: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.3.6.6.3.1 Rest of Asia Pacific: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)0
10.3.6.6.3.2 Rest of Asia Pacific: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.6.3.3 Rest of Asia Pacific: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.6.3.4 Rest of Asia Pacific: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)1
10.3.6.6.3.5 Rest of Asia Pacific: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.3.6.6.4 Rest of Asia Pacific: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)2
10.3.6.6.5 Rest of Asia Pacific: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.4 Middle East & Africa: Drug Delivery Market4
10.4.1 Overview4
10.4.2 Middle East & Africa: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
10.4.3 Middle East & Africa: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.4.3.1 Middle East & Africa: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)6
10.4.3.2 Middle East & Africa: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.4.3.3 Middle East & Africa: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.4.3.4 Middle East & Africa: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)7
10.4.3.5 Middle East & Africa: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.4.4 Middle East & Africa: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)7
10.4.5 Middle East & Africa: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.4.6 Middle East & Africa: Drug Delivery Market, by Country, 2022 & 2028 (%)8
10.4.6.1 Saudi Arabia: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.4.6.1.1 Overview9
10.4.6.1.2 Saudi Arabia: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.4.6.1.3 Saudi Arabia: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.4.6.1.3.1 Saudi Arabia: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)1
10.4.6.1.3.2 Saudi Arabia: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.4.6.1.3.3 Saudi Arabia: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.4.6.1.3.4 Saudi Arabia: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)2
10.4.6.1.3.5 Saudi Arabia: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.4.6.1.4 Saudi Arabia: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)3
10.4.6.1.5 Saudi Arabia: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.4.6.2 UAE: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.4.6.2.1 Overview4
10.4.6.2.2 UAE: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
10.4.6.2.3 UAE: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.4.6.2.3.1 UAE: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)6
10.4.6.2.3.2 UAE: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.4.6.2.3.3 UAE: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.4.6.2.3.4 UAE: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)7
10.4.6.2.3.5 UAE: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.4.6.2.4 UAE: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)8
10.4.6.2.5 UAE: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.4.6.3 South Africa: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.4.6.3.1 Overview9
10.4.6.3.2 South Africa: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.4.6.3.3 South Africa: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.4.6.3.3.1 South Africa: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)1
10.4.6.3.3.2 South Africa: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.4.6.3.3.3 South Africa: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.4.6.3.3.4 South Africa: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)2
10.4.6.3.3.5 South Africa: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.4.6.3.4 South Africa: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)3
10.4.6.3.5 South Africa: Drug Delivery Market, by End User 2020-2028 (US$ Million)3
10.4.6.4 Rest of Middle East & Africa: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.4.6.4.1 Overview4
10.4.6.4.2 Rest of Middle East & Africa: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.4.6.4.3 Rest of Middle East & Africa: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.4.6.4.3.1 Rest of Middle East & Africa: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)5
10.4.6.4.3.2 Rest of Middle East & Africa: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.4.6.4.3.3 Rest of Middle East & Africa: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.4.6.4.3.4 Rest of Middle East & Africa: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)6
10.4.6.4.3.5 Rest of Middle East & Africa: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.4.6.4.4 Rest of Middle East & Africa: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)7
10.4.6.4.5 Rest of Middle East & Africa: Drug Delivery Market, by End User 2020-2028 (US$ Million)8
10.5 South & Central America: Drug Delivery Market9
10.5.1 Overview9
10.5.2 South & Central America: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
10.5.3 South & Central America: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.5.3.1 South & Central America: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)1
10.5.3.2 South & Central America: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.5.3.3 South & Central America: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.5.3.4 South & Central America: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)2
10.5.3.5 South & Central America: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.5.4 South & Central America: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)3
10.5.5 South & Central America: Drug Delivery Market, by End User, 2020-2028 (US$ Million)3
10.5.6 South & Central America: Drug Delivery Market, by Country, 2022 & 2028 (%)4
10.5.6.1 Brazil: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.5.6.1.1 Overview4
10.5.6.1.2 Brazil: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
10.5.6.1.3 Brazil: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.5.6.1.3.1 Brazil: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)6
10.5.6.1.3.2 Brazil: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.5.6.1.3.3 Brazil: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.5.6.1.3.4 Brazil: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)7
10.5.6.1.3.5 Brazil: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.5.6.1.4 Brazil: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)8
10.5.6.1.5 Brazil: Drug Delivery Market, by End User, 2020-2028 (US$ Million)8
10.5.6.2 Argentina: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.5.6.2.1 Overview9
10.5.6.2.2 Argentina: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
10.5.6.2.3 Argentina: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)0
10.5.6.2.3.1 Argentina: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)0
10.5.6.2.3.2 Argentina: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)1
10.5.6.2.3.3 Argentina: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)1
10.5.6.2.3.4 Argentina: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)1
10.5.6.2.3.5 Argentina: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)2
10.5.6.2.4 Argentina: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)2
10.5.6.2.5 Argentina: Drug Delivery Market, by End User, 2020-2028 (US$ Million)3
10.5.6.3 Rest of South & Central America: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.5.6.3.1 Overview4
10.5.6.3.2 Rest of South & Central America: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
10.5.6.3.3 Rest of South & Central America: Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)5
10.5.6.3.3.1 Rest of South & Central America: Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)5
10.5.6.3.3.2 Rest of South & Central America: Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)6
10.5.6.3.3.3 Rest of South & Central America: Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)6
10.5.6.3.3.4 Rest of South & Central America: Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)7
10.5.6.3.3.5 Rest of South & Central America: Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)7
10.5.6.3.4 Rest of South & Central America: Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)8
10.5.6.3.5 Rest of South & Central America: Drug Delivery Market, by End User, 2020-2028 (US$ Million)8
11. Impact Of COVID-19 Pandemic on Drug Delivery Market9
11.1 North America: Assessment of COVID-19 Pandemic9
11.2 Europe: Impact Assessment of COVID-19 Pandemic0
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic2
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic4
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic6
12. Drug Delivery Market – Industry Landscape7
12.1 Overview7
12.2 Growth Strategies in Drug Delivery Market7
12.3 Organic Growth Strategies8
12.3.1 Overview8
12.4 Inorganic Growth Strategies1
12.4.1 Overview1
13. Company Profiles2
13.1 Becton Dickinson and Co2
13.1.1 Key Facts2
13.1.2 Business Description2
13.1.3 Products and Services3
13.1.4 Financial Overview4
13.1.5 SWOT Analysis6
13.1.6 Key Developments7
13.2 Novo Nordisk AS8
13.2.1 Key Facts8
13.2.2 Business Description8
13.2.3 Products and Services9
13.2.4 Financial Overview0
13.2.5 SWOT Analysis1
13.2.6 Key Developments2
13.3 Boston Scientific Corp3
13.3.1 Key Facts3
13.3.2 Business Description3
13.3.3 Products and Services3
13.3.4 Financial Overview4
13.3.5 SWOT Analysis5
13.3.6 Key Developments5
13.4 Baxter International Inc6
13.4.1 Key Facts6
13.4.2 Business Description6
13.4.3 Products and Services7
13.4.4 Financial Overview7
13.4.5 SWOT Analysis9
13.4.6 Key Developments0
13.5 Gerresheimer AG1
13.5.1 Key Facts1
13.5.2 Business Description1
13.5.3 Products and Services1
13.5.4 Financial Overview2
13.5.5 SWOT Analysis4
13.5.6 Key Developments4
13.6 Kindeva Drug Delivery LP5
13.6.1 Key Facts5
13.6.2 Business Description5
13.6.3 Products and Services5
13.6.4 Financial Overview5
13.6.5 SWOT Analysis6
13.6.6 Key Developments7
13.7 GlaxoSmithKline Plc8
13.7.1 Key Facts8
13.7.2 Business Description8
13.7.3 Products and Services9
13.7.4 Financial Overview0
13.7.5 SWOT Analysis2
13.7.5.1 Key Developments2
13.8 Bausch Health Companies Inc3
13.8.1 Key Facts3
13.8.2 Business Description3
13.8.3 Products and Services3
13.8.4 Financial Overview5
13.8.5 SWOT Analysis7
13.8.6 Key Developments8
13.9 Boehringer Ingelheim International GmbH9
13.9.1 Key Facts9
13.9.2 Business Description9
13.9.3 Products and Services0
13.9.4 Financial Overview1
13.9.5 SWOT Analysis3
13.9.6 Key Developments3
13.10 Novartis AG4
13.10.1 Key Facts4
13.10.2 Business Description4
13.10.3 Products and Services5
13.10.4 Financial Overview6
13.10.5 SWOT Analysis8
13.10.6 Key Developments8
13.11 Sever Pharma Solutions9
13.11.1 Key Facts9
13.11.2 Business Description9
13.11.3 Products and Services9
13.11.4 Financial Overview9
13.11.5 SWOT Analysis0
13.11.6 Key Developments0
13.12 Johnson & Johnson1
13.12.1 Key Facts1
13.12.2 Business Description1
13.12.3 Products and Services2
13.12.4 Financial Overview2
13.12.5 SWOT Analysis4
13.12.6 Key Developments5
13.13 Pfizer Inc6
13.13.1 Key Facts6
13.13.2 Business Description6
13.13.3 Products and Services7
13.13.4 Financial Overview8
13.13.5 SWOT Analysis9
13.13.6 Key Developments0
14. Appendix1
14.1 About The Insight Partners1
14.2 Glossary of Terms2
LIST OF TABLES
Table 1. North America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)6
Table 2. North America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 3. North America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 4. North America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 5. North America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)8
Table 6. North America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)8
Table 7. North America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)8
Table 8. North America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 9. US Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)1
Table 10. US Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 11. US Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 12. US Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 13. US Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)3
Table 14. US Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)3
Table 15. US Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)4
Table 16. US Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)4
Table 17. Canada Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)6
Table 18. Canada Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 19. Canada Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 20. Canada Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 21. Canada Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)8
Table 22. Canada Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)8
Table 23. Canada Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)9
Table 24. Canada Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 25. Mexico Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)1
Table 26. Mexico Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 27. Mexico Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 28. Mexico Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 29. Mexico Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)3
Table 30. Mexico Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)3
Table 31. Mexico Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)4
Table 32. Mexico Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)4
Table 33. Europe Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)6
Table 34. Europe Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 35. Europe Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 36. Europe Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 37. Europe Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 38. Europe Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)8
Table 39. Europe Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)8
Table 40. Europe Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 41. UK Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 42. UK Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 43. UK Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 44. UK Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 45. UK Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 46. UK Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 47. UK Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)2
Table 48. UK Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 49. Germany Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 50. Germany Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)5
Table 51. Germany Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 52. Germany Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 53. Germany Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 54. Germany Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 55. Germany Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)7
Table 56. Germany Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 57. France Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 58. France Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)0
Table 59. France Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 60. France Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 61. France Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 62. France Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 63. France Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)2
Table 64. France Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 65. Spain Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 66. Spain Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)5
Table 67. Spain Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 68. Spain Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 69. Spain Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 70. Spain Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 71. Spain Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)7
Table 72. Spain Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 73. Italy Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 74. Italy Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)0
Table 75. Italy Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 76. Italy Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 77. Italy Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 78. Italy Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 79. Italy Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)2
Table 80. Italy Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 81. Rest of Europe Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 82. Rest of Europe Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)5
Table 83. Rest of Europe Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 84. Rest of Europe Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 85. Rest of Europe Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 86. Rest of Europe Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 87. Rest of Europe Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)7
Table 88. Rest of Europe Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 89. Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 90. Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 91. Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 92. Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 93. Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 94. Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 95. Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)2
Table 96. Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 97. China Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 98. China Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)5
Table 99. China Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 100. China Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 101. China Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 102. China Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 103. China Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)7
Table 104. China Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 105. Japan Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 106. Japan Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)0
Table 107. Japan Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 108. Japan Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 109. Japan Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 110. Japan Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 111. Japan Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)2
Table 112. Japan Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 113. India Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 114. India Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 115. India Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 116. India Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 117. India Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 118. India Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 119. India Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)7
Table 120. India Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 121. South Korea Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 122. South Korea Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 123. South Korea Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 124. South Korea Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 125. South Korea Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 126. South Korea Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 127. South Korea Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)3
Table 128. South Korea Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 129. Australia Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 130. Australia Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 131. Australia Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 132. Australia Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 133. Australia Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 134. Australia Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 135. Australia Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)8
Table 136. Australia Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 137. Rest of Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 138. Rest of Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)0
Table 139. Rest of Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 140. Rest of Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 141. Rest of Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 142. Rest of Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 143. Rest of Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)2
Table 144. Rest of Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 145. Middle East & Africa Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 146. Middle East & Africa Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 147. Middle East & Africa Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 148. Middle East & Africa Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 149. Middle East & Africa Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 150. Middle East & Africa Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 151. Middle East & Africa Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)7
Table 152. Middle East & Africa Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 153. Saudi Arabia Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 154. Saudi Arabia Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 155. Saudi Arabia Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 156. Saudi Arabia Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 157. Saudi Arabia Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 158. Saudi Arabia Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 159. Saudi Arabia Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)3
Table 160. Saudi Arabia Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 161. UAE Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 162. UAE Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 163. UAE Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 164. UAE Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 165. UAE Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 166. UAE Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 167. UAE Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)8
Table 168. UAE Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 169. South Africa Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 170. South Africa Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 171. South Africa Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 172. South Africa Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 173. South Africa Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 174. South Africa Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 175. South Africa Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)3
Table 176. South Africa Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 177. Rest of Middle East & Africa Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 178. Rest of Middle East & Africa Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)5
Table 179. Rest of Middle East & Africa Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 180. Rest of Middle East & Africa Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 181. Rest of Middle East & Africa Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 182. Rest of Middle East & Africa Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 183. Rest of Middle East & Africa Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)7
Table 184. Rest of Middle East & Africa Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 185. South & Central America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 186. South & Central America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 187. South & Central America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 188. South & Central America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 189. South & Central America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 190. South & Central America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 191. South & Central America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)3
Table 192. South & Central America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 193. Brazil Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 194. Brazil Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 195. Brazil Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 196. Brazil Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 197. Brazil Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 198. Brazil Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 199. Brazil Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)8
Table 200. Brazil Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 201. Argentina Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)0
Table 202. Argentina Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)0
Table 203. Argentina Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 204. Argentina Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 205. Argentina Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)1
Table 206. Argentina Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)2
Table 207. Argentina Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)2
Table 208. Argentina Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 209. Rest of South & Central America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)5
Table 210. Rest of South & Central America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)5
Table 211. Rest of South & Central America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 212. Rest of South & Central America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)6
Table 213. Rest of South & Central America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 214. Rest of South & Central America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)7
Table 215. Rest of South & Central America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)8
Table 216. Rest of South & Central America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 217. Recent Organic Growth Strategies in Drug Delivery Market8
Table 218. Recent Inorganic Growth Strategies in the Drug Delivery Market1
Table 219. Glossary of Terms, Drug delivery market2
LIST OF FIGURES
Figure 1. Drug Delivery Market Segmentation
Figure 2. Drug Delivery Market by Region
Figure 3. Global Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in Drug Delivery Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Drug Delivery Market, by Geography (US$ Million)
Figure 7. Global Drug Delivery Market – Leading Country Markets (US$ Million)
Figure 8. Global Drug Delivery Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 16. Global Drug Delivery Market – Revenue Forecast and Analysis – 2020–2028
Figure 17. Global Drug Delivery Market, by Geography – Forecast and Analysis (2022–2028)
Figure 18. Market Positioning of Key Players in the Drug Delivery Market
Figure 19. Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
Figure 20. Injectable Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Conventional Injection Devices: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Advanced Devices: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Oral Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Solid Oral Drugs: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Liquid Oral Drugs: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Semi-solid Oral Drugs: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Topical Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Semi-solid Topical Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Liquid Topical Drug Delivery Formulations: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Solid Topical Drug Delivery Formulations: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Transdermal Patches: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Transmucosal Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Pulmonary Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Buccal and Sublingual Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rectal Transmucosal Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Vaginal Transmucosal Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Implantable Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Ocular Drug Delivery: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Eye Drops and Sprays: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Gels and Ointments: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Ocular Inserts and Punctal Plugs: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Therapeutic Contact Lens: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 44. Hospital Pharmacies: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Retail Pharmacies: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Online Pharmacies: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 47. Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)1
Figure 48. Hospitals and Clinics: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)2
Figure 49. Home Care Settings: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)3
Figure 50. Other End User: Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 51. North America: Drug Delivery Market, by Key Country – Revenue (2022) (US$ Million)5
Figure 52. North America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)6
Figure 53. North America: Drug Delivery Market, by Country, 2022 & 2028 (%)9
Figure 54. US: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)1
Figure 55. Canada: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)6
Figure 56. Mexico: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)1
Figure 57. Europe: Drug Delivery Market, by Key Country – Revenue (2022) (US$ Million)5
Figure 58. Europe Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)5
Figure 59. Europe: Drug Delivery Market, by Country, 2022 & 2028 (%)9
Figure 60. UK: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 61. Germany: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 62. France: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 63. Spain: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 64. Italy: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 65. Rest of Europe: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 66. Asia Pacific: Drug Delivery Market, by Key Country – Revenue (2022) (US$ Million)9
Figure 67. Asia Pacific Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)0
Figure 68. Asia Pacific: Drug Delivery Market, by Country, 2022 & 2028 (%)3
Figure 69. China: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 70. Japan: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 71. India: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 72. South Korea: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 73. Australia: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 74. Rest of Asia Pacific: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 75. Middle East & Africa: Drug Delivery Market, by Key Country – Revenue (2022) (US$ Million)4
Figure 76. Middle East & Africa Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 77. Middle East & Africa: Drug Delivery Market, by Country, 2022 & 2028 (%)8
Figure 78. Saudi Arabia: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 79. UAE: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 80. South Africa: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 81. Rest of Middle East & Africa: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 82. South & Central America: Drug Delivery Market, by Key Country – Revenue (2022) (US$ Million)9
Figure 83. South & Central America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)0
Figure 84. South & Central America: Drug Delivery Market, by Country, 2022 & 2028 (%)4
Figure 85. Brazil: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 86. Argentina: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 87. Rest of South & Central America: Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 88. Impact of COVID-19 Pandemic on North American Country Markets0
Figure 89. Impact of COVID-19 Pandemic on European Country Markets1
Figure 90. Impact of COVID-19 Pandemic on Asia Pacific Country Markets3
Figure 91. Impact of COVID-19 Pandemic on Middle East & African Country Markets5
Figure 92. Impact of COVID-19 Pandemic on South & Central America Country Markets6
Figure 93. Growth Strategies in Drug Delivery Market7
The List of Companies - Drug Delivery Market
- Becton, Dickinson and Co
- Novo Nordisk AS
- Boston Scientific Corp
- Baxter International Inc
- Gerresheimer AG
- Kindeva Drug Delivery LP
- GlaxoSmithKline Plc
- Bausch Health Companies
- Novartis AG
- Boehringer Ingelheim International
- Sever Pharma Solutions
- Pfizer Inc.
- Johnson & Johnson.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Drug Delivery Market
May 2023
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2023
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2023
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2023
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2023
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)